<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01614158</url>
  </required_header>
  <id_info>
    <org_study_id>73/2009B02</org_study_id>
    <nct_id>NCT01614158</nct_id>
  </id_info>
  <brief_title>Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy</brief_title>
  <acronym>Pilot-SINN</acronym>
  <official_title>Pilot SINN; Assessment of Visual Field (vf)-Related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy (N-AION)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Freiburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This present research project intends to collect five quantitative test series:

        -  perimetric examination using static stimuli, assessing the entire (80 degree) visual
           field with a fast thresholding algorithm (GATE) [Schiefer 2008] to know the extent/
           magnitude of the visual field defect and its variability within the cohort and over time

        -  D-BCVA, using FrACT [Bach 2007] and EDTRS chart [Ferris 1982]

        -  RAPD (using swinging flashlight test).

        -  IOP (using applanation tonometer)

        -  RNFT and RNFV using Spectralis OCT (star scan, ring scan 2,8 mm, and volume scan) Optic
           disk morphology will be documented by fundus photography. This assessment of the
           above-mentioned data is needed in order to allow for estimation of the spontaneous
           course / fluctuation of the (quantified) functional and morphometric parameters of the
           N-AION patients during the follow-up period. This is essential for the estimation of the
           sample size of the subsequently intended SINN study, that is intended to compare
           different therapeutic strategies in N-AION patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of visual field (VF)-related endpoints in patients with non-arteritic ischemic optic neuropathy (N-AION)</measure>
    <time_frame>2 years</time_frame>
    <description>This present research project intends to collect five quantitative test series in order to allow the estimation of the spontaneous course / fluctuation of the (quantified) functional and morphometric parameters of the N-AION patients during the follow-up period. This is essential for the estimation of the sample size of the subsequently intended SINN study, that is intended to compare different therapeutic strategies in N-AION patients</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">16</enrollment>
  <condition>Non-arteritic Ischemic Optic Neuropathy</condition>
  <arm_group>
    <arm_group_label>acute N-AION (&lt; 7 d)</arm_group_label>
    <description>physical, intellectual and linguistic abilities, in order to understand the test requirements
willingness to comply with the protocol (4 visits)
45 - 80 years, informed consent
acute N-AION (&lt; 7 d)
D-BCVA &gt; 0.1 (2/20)
RAPD ≥ 0.3 logE steps (neutral density filters)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>perimetry</intervention_name>
    <description>perimetric examination using static stimuli, assessing the entire (80 degree) visual field with a fast thresholding algorithm (GATE) [Schiefer 2008] to know the extent/ magnitude of the visual field defect and its variability within the cohort and over time</description>
    <arm_group_label>acute N-AION (&lt; 7 d)</arm_group_label>
    <other_name>Static Perimetry, Octopus 101, thresholding algorithm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>D-BCVA</intervention_name>
    <description>D-BCVA using EDTRS chart</description>
    <arm_group_label>acute N-AION (&lt; 7 d)</arm_group_label>
    <other_name>Best Corrected Visual Acuity, EDTRS Chart</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RAPD</intervention_name>
    <description>RAPD using swinging flashlight test</description>
    <arm_group_label>acute N-AION (&lt; 7 d)</arm_group_label>
    <other_name>SWIFT-Test</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IOP</intervention_name>
    <description>IOP using applanation tonometer</description>
    <arm_group_label>acute N-AION (&lt; 7 d)</arm_group_label>
    <other_name>intraocular pressure</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectralis OCT</intervention_name>
    <description>RNFT and RNFV using Spectralis OCT (star scan, ring scan 2,8 mm and volume scan)</description>
    <arm_group_label>acute N-AION (&lt; 7 d)</arm_group_label>
    <other_name>RNFT, RNFV, volume scan, star scan, Spectralis OCT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fundus photography</intervention_name>
    <description>Optic disk morphology will be documented by fundus photography</description>
    <arm_group_label>acute N-AION (&lt; 7 d)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute N-AION (less then 7 days); male and female &gt; 18 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: - physical, intellectual and linguistic abilities, in order to
        understand the test requirements

          -  willingness to comply with the protocol (4 visits)

          -  41 - 80 years, informed consent

          -  acute N-AION (&lt; 7 d)

          -  D-BCVA &gt; 0.1 (2/20)

          -  RAPD ≥ 0.3 logE steps (neutral density filters) and:

          -  spherical ametropia max. ± 8 dpt, cylindrical ametropia max. ± 3 dpt

          -  isocoria, pupil diameter &gt; 3 mm

        Exclusion Criteria:

          -  diabetic retinopathy and any other orbital, intracranial or optic nerve disease

          -  history of epilepsy or significant psychiatric disease

          -  medications known to affect visual field sensitivity

          -  infections (e.g. keratitis, conjunctivitis, uveitis)

          -  severe dry eyes

          -  miotic drug

          -  amblyopia

          -  strabismus

          -  any ocular pathology, in either eye, that may interfere with the ability to obtain
             visual fields, disc imaging or accurate IOP readings

          -  cataract with relevant impairment of vision

          -  keratoconus

          -  intraocular surgery (except for uncomplicated cataract surgery) performed &lt; 3 month
             prior to screening

          -  history or signs of any visual pathway affection other than N-AION

          -  history or presence of macular disease and / or macular edema

          -  ocular trauma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Schiefer, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Ophthalmology Institute for Ophthalmic Research University of Tübingen</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Kernstock C, Beisse F, Wiethoff S, Mast A, Krapp E, Grund R, Dietzsch J, Lagrèze W, Fischer D, Schiefer U. Assessment of functional and morphometric endpoints in patients with non-arteritic anterior ischemic optic neuropathy (NAION). Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):515-21. doi: 10.1007/s00417-014-2572-z. Epub 2014 Jan 31.</citation>
    <PMID>24477537</PMID>
  </results_reference>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2012</study_first_submitted>
  <study_first_submitted_qc>June 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2012</study_first_posted>
  <last_update_submitted>May 27, 2014</last_update_submitted>
  <last_update_submitted_qc>May 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Ulrich Schiefer</investigator_full_name>
    <investigator_title>Professor Dr. med. Ulrich Schiefer</investigator_title>
  </responsible_party>
  <keyword>N-AION</keyword>
  <keyword>perimetry</keyword>
  <keyword>visual field loss</keyword>
  <keyword>Mean Defect</keyword>
  <keyword>Total Loss Volume</keyword>
  <keyword>D-BCVA</keyword>
  <keyword>RAPD</keyword>
  <keyword>retinal nerve fibre thickness/volume</keyword>
  <keyword>optic nerve head</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Optic Nerve Diseases</mesh_term>
    <mesh_term>Optic Neuropathy, Ischemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

